On 29 October 2025, the board of directors of the Company (Stock Code: 1209) confirmed the adoption of the updated Nomination Committee Terms of Reference, originally resolved on 19 November 2020.

According to the announcement, the Nomination Committee must have at least three members, with a majority being independent non-executive directors who meet relevant independence standards. Meetings shall be convened at least once a year, and notices for such meetings must be issued at least two working days prior to convening.

The Nomination Committee is authorized to review the structure, size, and composition of the board, assess the independence of independent non-executive directors, and recommend suitable candidates for directorship and re-appointment. The announcement further indicates that the Nomination Committee can seek information from company employees and, when necessary, consult external professionals for independent advice. The updated Terms of Reference highlight responsibilities consistent with the Corporate Governance Code, ensuring the Nomination Committee has sufficient resources and clear reporting procedures to carry out its duties effectively.

In addition, the Terms of Reference specify that the chairman and members of the Nomination Committee should attend annual general meetings to address any shareholder inquiries regarding the committee’s responsibilities. These measures seek to strengthen corporate governance by clarifying the structure, authority, and procedures of the Nomination Committee, enhancing the process of board appointments and related oversight.